Investors aiming for above-average returns often turn to the practice of stock picking. Skillful choices in individual stocks can be a catalyst for substantial wealth growth.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
After finishing at $12.49 in the prior trading day, Immunome Inc (NASDAQ: IMNM) closed at $11.59, down -7.21%. In other words, the price has decreased by -$7.21 from its previous closing price. On the day, 0.61 million shares were traded. IMNM stock price reached its highest trading level at $12.7727 during the session, while it also had its lowest trading level at $11.55.
Ratios:
Our goal is to gain a better understanding of IMNM by taking a closer look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 7.12 and its Current Ratio is at 7.12. In the meantime, Its Debt-to-Equity ratio is 0.01 whereas as Long-Term Debt/Eq ratio is at 0.01.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Stephens on November 08, 2024, initiated with a Overweight rating and assigned the stock a target price of $30.
On May 31, 2024, Piper Sandler started tracking the stock assigning a Overweight rating and target price of $27.
On April 30, 2024, JP Morgan started tracking the stock assigning a Overweight rating and target price of $24.JP Morgan initiated its Overweight rating on April 30, 2024, with a $24 target price.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Sep 19 ’24 when Rosett Max sold 14,380 shares for $16.01 per share. The transaction valued at 230,224 led to the insider holds 47,476 shares of the business.
Rosett Max bought 14,380 shares of IMNM for $230,211 on Sep 19 ’24. On Aug 16 ’24, another insider, BIENAIME JEAN JACQUES, who serves as the Director of the company, bought 7,000 shares for $13.94 each. As a result, the insider paid 97,608 and bolstered with 16,615 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, IMNM now has a Market Capitalization of 721884288 and an Enterprise Value of 420449184. For the stock, the TTM Price-to-Sale (P/S) ratio is 64.57 while its Price-to-Book (P/B) ratio in mrq is 2.74. Its current Enterprise Value per Revenue stands at 38.988 whereas that against EBITDA is -5.876.
Stock Price History:
Over the past 52 weeks, IMNM has reached a high of $30.96, while it has fallen to a 52-week low of $6.93. The 50-Day Moving Average of the stock is -12.56%, while the 200-Day Moving Average is calculated to be -28.70%.
Shares Statistics:
The stock has traded on average 606.18K shares per day over the past 3-months and 517900 shares per day over the last 10 days, according to various share statistics. A total of 60.05M shares are outstanding, with a floating share count of 48.99M. Insiders hold about 18.42% of the company’s shares, while institutions hold 81.65% stake in the company. Shares short for IMNM as of 1730332800 were 10468711 with a Short Ratio of 17.27, compared to 1727654400 on 12878019. Therefore, it implies a Short% of Shares Outstanding of 10468711 and a Short% of Float of 17.740000000000002.
